July 30, 2019 Mylan gets an injection, administered by Pfizer The combination of Upjohn and Mylan means that, for a change, Pfizer is getting smaller. But will the company’s new chief executive really be able to resist the urge to merge?
May 14, 2019 Price fixing case caps a terrible week for generics Shares in generics firms tumble in the wake of a huge lawsuit in the US alleging industry-wide price fixing, signalling many more years of pain for this sector.
March 17, 2017 Snippet roundup: Medica and Cell Medica are in the money, but Endo and Valeant feel the pain
